Factors Associated with Mortality in COVID-19 Patients Treated at Serui General Hospital, Papua Indonesia

Fahri Ahmad Baihaqi, Henny Rumaropen

Abstract


Coronavirus Disease 2019 (COVID-19) has a high fatality rate and has caused around 4,771,408 deaths worldwide as of 30 September 2021. COVID-19 infection presents various severity levels, starting from asymptomatic to severe symptoms that lead to death. Mortality in COVID-19 patients is associated with multiple risk factors. This study aimed to analyze the risk factors associated with COVID-19 mortality in Serui General Hospital, Papua, Indonesia. A cross-sectional analytic observational study was performed in Serui General Hospital from September 2020to September 2021. Subjects were COVID-19 positive inpatients who met the inclusion and exclusion criteria. The independent variables were demographic characteristics, clinical manifestations, comorbidities, and lab findings, while the dependent variable was mortality. Statistical analysis was performed using chi-square test and logistic regression. This study included sixty-nine patients with 21 (30.4%) of them were non-survivors. The multivariate analysis showed that an NLR of >3.13 (OR 7.49; p=0.037; 95% CI 1.63–34.35), hypertension (OR 4.71; p=0.019; 95% CI 1.28–17.29), and age (OR 4.26; p=0.028; 95% CI 1.17–15.52) were associated with mortality in COVID-19 patients. Thus, NLR >3.13, hypertension, and age are considered to be the risk factors associated with the mortality caused by COVID-19 among patients in Serui General Hospital.


Keywords


COVID-19; mortality; risk factors

Full Text:

PDF

References


  1. World Health Organization (WHO). Naming the coronavirus disease (COVID-19) and the virus that cause it. Geneva: 2020 [cited 2021 October 1]. Available from: https://www.who.int/emergencies/disease/novelcoronavirus-2019/technical guidance/namingthe-coronavirus-disease-(covid-2019)-andthe-virus-that-causes-it.
  2. World Health Organization (WHO). WHO Coronavirus (COVID-19) Dashboard. Geneva: 2021 [cited 2021 October 1]. Available from: https://covid19.who.int/.
  3. Badan Nasional Penanggulangan Bencana. Satuan Tugas Penanganan (BNPB) COVID-19; 2021 [cited 2021 October 2]. Available from: https://covid19.go.id/peta-sebaran-covid19.
  4. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061.
  5. Pourbagheri-Sigaroodi A, Bashash D, Fateh F, Abolghasemi H. Laboratory findings in COVID-19 diagnosis and prognosis. Clin Chimica Acta. 2020;510:475–82.
  6. Sulistyowati E, Muninggar S, Silalahi V. Risk factors of covid-19 confirmed died patients in Dr. Kariadi Hospital: A Retrospective Study. Indonesian J Tropical Infect Dis. 2021;9(1):1.
  7. Vafadar Moradi E, Teimouri A, Rezaee R, Morovatdar N, Foroughian M, Layegh P, et al. Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality. Am J Emerg Med. 2021;40:11–4.
  8. Li M, Cheng B, Zeng W, Chen S, Tu M, Wu M, et al. Analysis of the risk factors for mortality in adult COVID-19 patients in Wuhan: a multicenter study. Front Med (Lausanne). 2020;7:545.
  9. Kim W, Han JM, Lee KE. Predictors of mortality in patients with COVID-19: A systematic review and meta-analysis. Korean J Clin Pharm. 2020;30:169–76.
  10. Rozaliyani A, Savitri AI, Setianingrum F, Shelly TN, Ratnasari V, Kuswindarti R, et al. Factors associated with death in COVID-19 patients in Jakarta, Indonesia: an epidemiological study. Acta Med Indones. 2020;52(3):246–54.
  11. Surendra H, Elyazar IR, Djaafara BA, Ekawati LL, Saraswati K, Adrian V, et al. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study. Lancet Reg Health West Pac. 2021;9:100108.
  12. Pranata R, Lim MA, Huang I, Raharjo SB, Lukito AA. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression. J Renin Angiotensin Aldosterone Syst. 2020;21(2):1470320320926899.
  13. Chen G, Li X, Gong Z, Xia H, Wang Y, Wang X, et al. Hypertension as a sequela in patients of SARS-CoV-2 infection. PLoS One. 2021;16(4):e0250815.
  14. Song H, Kim HJ, Park KN, Kim SH, Oh SH, Youn CS. Neutrophil to lymphocyte ratio is associated with in-hospital mortality in older adults admitted to the emergency department. Am J Emerg Med. 2021;40:133–7.
  15. Allahverdiyev S, Quisi A, Harbalıoğlu H, Alıcı G, Genç Ö, Yıldırım A, et al. The neutrophil to lymphocyte ratio and in hospital all-cause mortality in patients with COVID-19. Eur J Ther. 2020;26(3):251–6.
  16. Liu Y, Du X, Chen J, Jin Y, Peng L, Wang H, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81(1):e6–12.
  17. Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39(5):529–39.
  18. Efrina D, Priyanto H, Andayani N, Arliny Y, Yanti B. Neutrophil to lymphocyte ratio as a marker of COVID-19 disease severity in Banda Aceh. J Respiro Indo. 2021;41(4):272–8.




DOI: https://doi.org/10.15395/mkb.v54n4.2864

Article Metrics

Abstract view : 290 times
PDF - 284 times

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


 


Creative Commons License
MKB is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

 


View My Stats